Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder
Launched by UNIVERSITY OF UTAH · Jun 3, 2024
Trial Information
Current as of February 19, 2025
Suspended
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help adults with a condition called REM Sleep Behavior Disorder (RBD), which often causes disturbing nightmares. The goal is to see if a non-medication treatment can reduce the frequency and intensity of these nightmares. If you or a loved one has been diagnosed with RBD and experiences nightmares at least three times a week, you might be eligible to participate. Participants need to be at least 18 years old, live in the U.S., and have a stable medication routine for sleep and other related issues. Additionally, it’s important to have a romantic partner who is willing to join in on the study.
Participants will take part in seven online sessions where they will learn techniques to improve their sleep and reduce nightmares. Their partners will join for two of those sessions. During the study, participants will also complete two assessments to track their progress. This trial is currently recruiting, and it provides an opportunity for those struggling with RBD and nightmares to try a new treatment approach while getting support from their partners.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of isolated RBD or RBD secondary to neurodegenerative disease
- • Age 18 or older
- • Speak, read, and write English
- • Live in the United States
- • Nightmare frequency ≥3 times per week
- • Disturbing Dream and Nightmare Severity Index score indicative of nightmare disorder
- • Sleep, neurological, and psychiatric medications stable for at least 1 month and willing to keep medications stable through the course of the study
- • Live with a romantic partner who is willing to participate in the study
- Exclusion Criteria:
- • Possible dementia
- • Narcolepsy
- • Posttraumatic stress disorder
- • Previous behavioral treatment for nightmares
- • Currently engaged in sleep- or trauma-focused psychotherapy
- • Taking a medication that could cause RBD, if the medication was started prior to onset of RBD symptoms
- Inclusion Criteria (Partners):
- • Live with a romantic partner who meets all of the above criteria
- • Age 18 or older
- • Speak, read, and write English
- • Live in the United States
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Salt Lake City, Utah, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
